Prolongation and enhancement of serum methotrexate concentrations by probenecid.
- 29 April 1978
- Vol. 1 (6120), 1097-1099
- https://doi.org/10.1136/bmj.1.6120.1097
Abstract
The disappearance of methotrexate (MTX) from the serum after an intravenous bolus injection and intravenous infusion was studied over 24 hours in eight and four patients respectively. Probenecid given at the same time as the bolus injection delayed the disappearance of MTX from the serum and resulted in enhanced concentrations throughout the 24 hours studied. At 24 hours the mean concentration was four times higher than in patients not given probenecid. Overall serum concentrations were even greater than those in patients who had received MTX by intravenous infusion. We suggest that smaller doses of MTX may be given and treatment costs thereby reduced if probenecid is given in addition.Keywords
This publication has 9 references indexed in Scilit:
- Development and application of a radioimmunoassay for methotrexateBritish Journal of Cancer, 1977
- Influence of probenecid and spironolactone on furosemide kinetics and dynamics in manClinical Pharmacology & Therapeutics, 1977
- Methotrexate: Distribution in Cerebrospinal Fluid after Intravenous, Ventricular and Lumbar InjectionsNew England Journal of Medicine, 1975
- Inhibition of renal tubular transport of methotrexate by probenecid.1975
- Pharmacokinetics of methotrexateClinical Pharmacology & Therapeutics, 1973
- The effect of organic acids on renal clearance of methotrexate in manClinical Pharmacology & Therapeutics, 1969
- Treatment of leukemia with large doses of methotrexate and folinic acid: clinical-biochemical correlatesJCI Insight, 1969
- The renal excretion of indomethacin and its inhibition by probenecidClinical Pharmacology & Therapeutics, 1968
- METABOLIC FATE OF TRITIATED METHOTREXATE .2. ABSORPTION AND EXCRETION IN MAN1965